French startup Naox Technologies this month became the first company to receive FDA 510(k) clearance for an in-ear EEG device. The system seeks to improve care for neurological conditions like epilepsy, Alzheimer’s and sleep disorders by capturing brain activity in everyday settings that traditional scalp-based EEGs often miss.
Ceribell Inc., based in Sunnyvale, California, has developed a point-of-care EEG system that provides real-time seizure monitoring and alerting, which helps in the rapid and precise treatment of patients with suspected non-convulsive seizures. The FDA-cleared Ceribell ClarityPro software uses a machine-learning model to analyze EEG signals and generate bedside alerts.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
This could be a good time to focus on the neurological device sector: The market for these tools is on the upswing and projected to hit $5 billion by 2020, thanks to an increase in neurological procedures (and better available technology), a report form Canadian firm iData Research says. The neuromodulation sector is expected to perform well, the report […]